Baby and kids' product recalls

The leg can become partially detached from the crib's headboard and footboard, posing an injury hazard.

Direct customer tested organic parsley upon receipt and received a confirmed positive result for Salmonella.

Direct customer tested organic parsley upon receipt and received a confirmed positive result for Salmonella.

The plastic characters on the recalled Sippy Cup contain levels of lead that exceed the federal lead content ban and contain levels of a regulated phthalate that exceed the prohibition of specific phthalates. Lead and banned phthalates are toxic if ingested by young children and can cause adverse health issues.

The products contain the substance methyl salicylate which must be in child resistant packaging as required by the Poison Prevention Packaging Act. The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.

FDA inspection identified that due to increased positivity (false positives) on the Parvovirus B19 ELISA Test System, the firm assigned a new Correction Factor and new lot number to the remainder of the affected lot, and distributed the reworked product to the customer.

Salmonella Newport. Product contains onion supplied from Thomson International, Inc.

The antifreeze products contain the substance ethylene glycol which must be in child resistant packaging as required by the Poison Prevention Packaging Act. The products' caps were not rotated enough during manufacturing to engage the child resistant mechanism, posing a risk of poisoning if the contents are swallowed by young children.

The multivitamins' packaging is not child resistant as required by the Poison Prevention Packaging Act. The capsules inside the bottle contain iron, which can cause serious injury or death to young children if multiple tablets are ingested at once.

An update to the carryover avoidance technical bulletin to introduce additional steps for reagent carryover avoidance with the Lactate Dehydrogenase assay on RX Instruments. Additional pipette washes can be implemented as described in the technical bulletin. Interference to the Lactate Dehydrogenase (LOH) reagent would be observed as inconsistencies in Quality Control recovery, which may lead to a delay in running patient samples, or erroneous elevated test results.

An update to the carryover avoidance technical bulletin to introduce additional steps for reagent carryover avoidance with the Lactate Dehydrogenase assay on RX Instruments. Additional pipette washes can be implemented as described in the technical bulletin. Interference to the Lactate Dehydrogenase (LOH) reagent would be observed as inconsistencies in Quality Control recovery, which may lead to a delay in running patient samples, or erroneous elevated test results.

The over-the-counter products contain regulated substances which must be in child resistant packaging when being used in the household as required by the Poison Prevention Packaging Act (PPPA). The packaging of the products is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.

The product contains the substance methyl salicylate which must be in child resistant packaging as required by the Poison Prevention Packaging Act (PPPA). The packaging of the product is not child resistant, posing a risk of poisoning if the contents are swallowed by young children.

Recall required by Order of Permanent Injunction. The products are misbranded and deemed unapproved drugs based on labeling claims.

Recall required by Order of Permanent Injunction. The products are misbranded and deemed unapproved drugs based on labeling claims.

Recall required by Order of Permanent Injunction. The products are misbranded and deemed unapproved drugs based on labeling claims.

Recall required by Order of Permanent Injunction. The products are misbranded and deemed unapproved drugs based on labeling claims.

Recall required by Order of Permanent Injunction. The products are misbranded and deemed unapproved drugs based on labeling claims.

Recall required by Order of Permanent Injunction. The products are misbranded and deemed unapproved drugs based on labeling claims.

Recall required by Order of Permanent Injunction. The products are misbranded and deemed unapproved drugs based on labeling claims.

Recall required by Order of Permanent Injunction. The products are misbranded and deemed unapproved drugs based on labeling claims.

Recall required by Order of Permanent Injunction. The products are misbranded and deemed unapproved drugs based on labeling claims.

Recall required by Order of Permanent Injunction. The products are misbranded and deemed unapproved drugs based on labeling claims.

Recall required by Order of Permanent Injunction. The products are misbranded and deemed unapproved drugs based on labeling claims.

Recall required by Order of Permanent Injunction. The products are misbranded and deemed unapproved drugs based on labeling claims.

Recall required by Order of Permanent Injunction. The products are misbranded and deemed unapproved drugs based on labeling claims.

Recall required by Order of Permanent Injunction. The products are misbranded and deemed unapproved drugs based on labeling claims.

Recall required by Order of Permanent Injunction. The products are misbranded and deemed unapproved drugs based on labeling claims.

Recall required by Order of Permanent Injunction. The products are misbranded and deemed unapproved drugs based on labeling claims.

Recall required by Order of Permanent Injunction. The products are misbranded and deemed unapproved drugs based on labeling claims.